CSIMarket
 
Inari Medical Inc   (NASDAQ: NARI)
 

Inari Medical Inc's Suppliers Performance

NARI's Supply Chain




 
NARI Costs vs Sales of Suppliers Growth Inari Medical Inc recorded an increase in cost of sales by 35.71 % year on year, relative to one quarter ago cost of sales fell by 0 % in Q3.

More on NARI Suppliers



Inari Medical Inc recorded increase in cost of sales by 35.71 % year on year, compare to one quarter ago cost of sales fell by 0 % in Q3.

More on NARI Suppliers




Inari Medical Inc's Comment on Supply Chain


The company utilizes both internally manufactured and externally sourced components for its medical device systems. For the LimFlow system, it relies exclusively on externally sourced components, third-party contract manufacturing, and finished goods assemblies. These components include off-the-shelf materials, sub-assemblies, and custom parts from approved suppliers, some of which are single-source. Supplier risk is managed through quality and capacity assessments, supply and quality agreements, lead time and inventory management, and efforts to identify alternative suppliers for dual or multi-sourcing. The company maintains sufficient supply levels to prevent interruptions and estimates up to six months to qualify a second source for certain components. Suppliers are evaluated, qualified, and approved via a supplier quality program that ensures compliance with FDA and ISO standards. Externally sourced components undergo inspection and verification under strict processes, and finished products are sterilized by qualified third-party suppliers.

Inari Medical Inc's Comment on Supply Chain


The company utilizes both internally manufactured and externally sourced components for its medical device systems. For the LimFlow system, it relies exclusively on externally sourced components, third-party contract manufacturing, and finished goods assemblies. These components include off-the-shelf materials, sub-assemblies, and custom parts from approved suppliers, some of which are single-source. Supplier risk is managed through quality and capacity assessments, supply and quality agreements, lead time and inventory management, and efforts to identify alternative suppliers for dual or multi-sourcing. The company maintains sufficient supply levels to prevent interruptions and estimates up to six months to qualify a second source for certain components. Suppliers are evaluated, qualified, and approved via a supplier quality program that ensures compliance with FDA and ISO standards. Externally sourced components undergo inspection and verification under strict processes, and finished products are sterilized by qualified third-party suppliers.







NARI's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Inari Medical Inc 4,665.22 572.18 -78.58 450
SUBTOTAL 0.00 0.00 0.00 -


Sources: Inari Medical Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Inari Medical Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.